Literature DB >> 22411324

Contained versus uncontained lesions in juvenile elbow osteochondritis dissecans.

Lewis L Shi1, Donald S Bae, Mininder S Kocher, Lyle J Micheli, Peter M Waters.   

Abstract

BACKGROUND: Juvenile osteochondritis dissecans (OCD) of the elbow typically affects the capitellum and may be "contained" (surrounded by intact cartilage) or "uncontained" (extending beyond the lateral cartilaginous margin). The purpose of this investigation was to compare the clinical presentation, radiographic findings, and surgical results of patients with contained versus uncontained lesions.
METHODS: Forty-three elbows in 42 patients who underwent surgery for OCD were followed for an average of 19.5 months. Average age at surgery was 14.2 years (range, 11.2 to 18.2 y); there were 16 female and 26 male patients. Preoperative magnetic resonance imaging was analyzed for location and size of the lesions, alignment and size of the radial head, presence of loose bodies, and lesion grades. Patients with contained and uncontained lesions were compared on the basis of preoperative characteristics, operative findings, and postoperative results.
RESULTS: During surgeries of the 43 elbows, 22 elbows had loose bodies, which were removed, 32 underwent drilling, and 6 lesions had internal fixation of the OCD lesion. Twenty-nine of the 43 elbows (67%) had contained lesions, and 14 (33%) were uncontained. Preoperatively, uncontained lesions had greater, but not statistically significant, flexion contractures (24.8 vs. 14.3 degrees, P=0.088), and more swelling (9/14, 64% vs. 7/29, 24%, P=0.007). There was a trend toward significance for the uncontained lesions to be larger (155 vs. 125 mm, P=0.15) and shallower (7.0 vs. 7.6 mm, P=0.07). Postoperatively, uncontained lesions again had greater flexion contracture (13.4 vs. 3.3 degrees, P=0.025).
CONCLUSIONS: At short-term follow-up, uncontained elbow OCD lesions have greater flexion contracture when compared with contained lesions. They also have higher rates of joint effusion and are broader and shallower than contained lesions. LEVEL OF EVIDENCE: Prognostic level IV.

Entities:  

Mesh:

Year:  2012        PMID: 22411324     DOI: 10.1097/BPO.0b013e31824afecf

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  8 in total

1.  Elbow injuries in the young athlete--an orthopedic perspective.

Authors:  Benjamin Zellner; Megan M May
Journal:  Pediatr Radiol       Date:  2013-03-12

2.  Is there any difference between open and arthroscopic treatment for osteochondritis dissecans of the humeral capitellum?

Authors:  Michel P J van den Bekerom; Roger van Riet
Journal:  Int Orthop       Date:  2018-03-15       Impact factor: 3.075

Review 3.  Osteochondritis dissecans of the elbow.

Authors:  Ryan W Churchill; Julianne Munoz; Christopher S Ahmad
Journal:  Curr Rev Musculoskelet Med       Date:  2016-06

4.  Demographics and Epidemiology of Osteochondritis Dissecans of the Elbow Among Children and Adolescents.

Authors:  Jeffrey I Kessler; John C Jacobs; Peter C Cannamela; Jennifer M Weiss; Kevin G Shea
Journal:  Orthop J Sports Med       Date:  2018-12-19

5.  Technique for Arthroscopic Debridement and Microfracture of Unstable, Contained Osteochondritis Dissecans Lesions of the Capitellum.

Authors:  Steven M DelBello; Larry D Field
Journal:  Arthrosc Tech       Date:  2020-03-24

Review 6.  Osteochondritis Dissecans of Smaller Joints: The Elbow.

Authors:  Juergen Bruns; Mathias Werner; Christian R Habermann
Journal:  Cartilage       Date:  2019-05-21       Impact factor: 4.634

Review 7.  Osteochondritis Dissecans of the Humeral Capitellum: The Significance of Lesion Location.

Authors:  Joel Kolmodin; Paul Saluan
Journal:  Orthop J Sports Med       Date:  2014-04-22

8.  The Incidence of Surgery in Osteochondritis Dissecans in Children and Adolescents.

Authors:  Jennifer M Weiss; Hooman Nikizad; Kevin G Shea; Samvel Gyurdzhyan; John C Jacobs; Peter C Cannamela; Jeffrey I Kessler
Journal:  Orthop J Sports Med       Date:  2016-03-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.